PDCD1 and neoplasm: one of the most important and effective immune checkpoint inhibitor molecules that hinders the function of the CAR T cells in tumor microenvironment is the program death that PD-1 negative CAR is designed to remain in the PD-L1 positive solid tumor microenvironment without limitation, which ameliorates the anti-tumor efficacy of CAR T cells (105).